Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?
Wilkes SR, Williams HC, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell EJ, Mason JM, Thomas KS; United Kingdom Dermatology Clinical Trials Network STOP GAP team. Wilkes SR, et al. Among authors: greenlaw n. J Am Acad Dermatol. 2016 Dec;75(6):1216-1220.e2. doi: 10.1016/j.jaad.2016.07.049. Epub 2016 Oct 11. J Am Acad Dermatol. 2016. PMID: 27742168
UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team. Craig FF, et al. Trials. 2012 Apr 28;13:51. doi: 10.1186/1745-6215-13-51. Trials. 2012. PMID: 22540770 Free PMC article. Clinical Trial.
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team. Ormerod AD, et al. Among authors: greenlaw n. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. BMJ. 2015. PMID: 26071094 Free PMC article. Clinical Trial.
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.
Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team. Thomas KS, et al. Among authors: greenlaw n. J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502313
A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease.
Thomas KS, Batchelor JM, Bath-Hextall F, Chalmers JR, Clarke T, Crowe S, Delamere FM, Eleftheriadou V, Evans N, Firkins L, Greenlaw N, Lansbury L, Lawton S, Layfield C, Leonardi-Bee J, Mason J, Mitchell E, Nankervis H, Norrie J, Nunn A, Ormerod AD, Patel R, Perkins W, Ravenscroft JC, Schmitt J, Simpson E, Whitton ME, Williams HC. Thomas KS, et al. Among authors: greenlaw n. Southampton (UK): NIHR Journals Library; 2016 Dec. Southampton (UK): NIHR Journals Library; 2016 Dec. PMID: 27977093 Free Books & Documents. Review.
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease.
Kalra PR, Greenlaw N, Ferrari R, Ford I, Tardif JC, Tendera M, Reid CM, Danchin N, Stepinska J, Steg PG, Fox KM; ProspeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) Investigators. Kalra PR, et al. Among authors: greenlaw n. Am J Med. 2017 Jun;130(6):720-730. doi: 10.1016/j.amjmed.2017.01.002. Epub 2017 Jan 19. Am J Med. 2017. PMID: 28109968 Free article.
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Mackenzie IS, Hawkey CJ, Ford I, Greenlaw N, Pigazzani F, Rogers A, Struthers AD, Begg AG, Wei L, Avery AJ, Taggar JS, Walker A, Duce SL, Barr RJ, Dumbleton JS, Rooke ED, Townend JN, Ritchie LD, MacDonald TM; ALL-HEART Study Group. Mackenzie IS, et al. Among authors: greenlaw n. Lancet. 2022 Oct 8;400(10359):1195-1205. doi: 10.1016/S0140-6736(22)01657-9. Lancet. 2022. PMID: 36216006 Free article. Clinical Trial.
Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial.
Cooper SA, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N, Haig C, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sirisena C, Sullivan F. Cooper SA, et al. Among authors: greenlaw n. Trials. 2016 Jul 29;17:370. doi: 10.1186/s13063-016-1370-9. Trials. 2016. PMID: 27473843 Free PMC article. Clinical Trial.
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
MacDonald TM, Hawkey CJ, Ford I, McMurray JJV, Scheiman JM, Hallas J, Findlay E, Grobbee DE, Hobbs FDR, Ralston SH, Reid DM, Walters MR, Webster J, Ruschitzka F, Ritchie LD, Perez-Gutthann S, Connolly E, Greenlaw N, Wilson A, Wei L, Mackenzie IS. MacDonald TM, et al. Among authors: greenlaw n. Eur Heart J. 2017 Jun 14;38(23):1843-1850. doi: 10.1093/eurheartj/ehw387. Eur Heart J. 2017. PMID: 27705888 Free PMC article. Clinical Trial.
86 results